|Day's Range||0.115 - 0.120|
|52 Week Range||0.110 - 0.190|
|PE Ratio (TTM)||7.67|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||0.70|
Categories: Yahoo Finance Get free summary analysis Regeneus Ltd. reports financial results for the half-year ended December 31, 2016. We analyze the earnings along side the following peers of Regeneus Ltd. – Polynovo Limited, Genera Biosystems Limited, Starpharma Holdings Limited and Pharmaust Limited (PNV-AU, GBI-AU, SPL-AU and PAA-AU) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)
Regeneus Ltd. , an Australian regenerative medicine company, has entered into an collaboration with a major Japanese firm to manufacture its stem cell therapy Progenza, a move that may accelerate approval ...
For the last two years, Japan has been at the forefront of accelerated approval for regenerative medicine products and has seen lots of licensing and contract manufacturing deals and M&A activity. Tokyo-based ...